Lab Automation In Drug Discovery Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Lab Automation In Drug Discovery Market Forecast Highlighting Growth From $7.11 Billion To $8.71 Billion
The market for lab automation in drug discovery has experienced robust expansion over the past few years. Projected to rise from $6.77 billion in 2025 to $7.12 billion in 2026, it reflects a compound annual growth rate (CAGR) of 5.1%. This historical growth has been driven by several factors, including the deployment of robotic arms in laboratory settings, heightened expenditure on pharmaceutical research and development, a growing need for error-reducing automation, the incorporation of lab information management systems, and advances in high-throughput screening methods.
The laboratory automation sector within drug discovery is anticipated to experience significant expansion over the coming years. By 2030, the market value is projected to reach $8.72 billion, reflecting a compound annual growth rate (CAGR) of 5.2%. This projected growth during the forecast period is driven by several key factors, including the rise of AI-enhanced drug discovery platforms, a heightened need for personalized therapeutics, the growing implementation of cloud-based laboratory management systems, the adoption of sophisticated robotics for sample processing, and an increase in strategic alliances between pharmaceutical and biotechnology firms. Among the pivotal trends shaping this period are the automation of high-throughput screening, the creation of integrated laboratory workflows, the application of predictive analytics in the discovery process, the downsizing of laboratory procedures, and the management of labs via cloud-based solutions.
Download A Free Sample Report For Comprehensive Market Insights:
Lab Automation In Drug Discovery Market Growth Momentum: Which Factors Are Influencing Demand?
The growing demand for personalized medicine is anticipated to drive advancements in laboratory automation within the drug discovery sector. This approach, often referred to as tailored therapy, customizes medical prevention and treatment by factoring in each person’s unique genetic, environmental, and lifestyle differences. By speeding up research, enhancing experimental reproducibility, and boosting the overall efficiency of precision medicine and drug development processes, lab automation facilitates the creation of more effective drugs and diagnostics designed for individual patients. As an example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit, noted that the FDA approved 16 new personalized treatments for rare diseases in 2023—a substantial jump from the six approvals seen in 2022. Thus, the escalating need for precision medicine is fueling the expansion of lab automation in the drug discovery market.
Lab Automation In Drug Discovery Market Segment Outlook: Which Categories Are Expanding The Fastest?
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems
Lab Automation In Drug Discovery Market Trends Reshaping Industry Growth
Major pharmaceutical firms in the lab automation segment of the drug discovery market are increasingly prioritising the incorporation of AI-driven and robotics-based systems to accelerate formulation development while boosting overall research and development productivity. Such AI-enhanced and robot-assisted platforms leverage sophisticated algorithms and automated machinery to improve task execution, elevate accuracy, and expedite operational workflows. As a notable illustration in May 2025, Intrepid Labs, a research laboratory based in Canada, officially introduced its Valiant platform—a system driven by artificial intelligence and robotics that is engineered to significantly fast-track drug formulation processes. Backed by over $11 million in total funding, which includes a recent $7 million seed round spearheaded by AVANT Bio, this initiative is designed to replace conventional slow and trial-driven formulation methods with rapid and data-informed optimisation approaches. The Valiant platform autonomously explores complete formulation design spaces, compressing timelines from months to just days while simultaneously enhancing both therapeutic efficacy and safety profiles. Since its establishment in 2023, Intrepid Labs has managed to forge collaborations with major pharmaceutical companies and contract research organisations, while also advancing proprietary oral and long-acting injectable technologies available for licensing.
Lab Automation In Drug Discovery Market Key Companies And Competitive Benchmarking
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation
Access The Complete Lab Automation In Drug Discovery Market Report:
Lab Automation In Drug Discovery Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
